An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations
- PMID: 17766701
- DOI: 10.1177/0091270007304457
An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations
Abstract
An integrated model for the regulation of glucose and insulin concentrations following intravenous glucose provocations in healthy volunteers and type 2 diabetic patients was developed. Data from 72 individuals were included. Total glucose, labeled glucose, and insulin concentrations were determined. Simultaneous analysis of all data by nonlinear mixed effect modeling was performed in NONMEM. Integrated models for glucose, labeled glucose, and insulin were developed. Control mechanisms for regulation of glucose production, insulin secretion, and glucose uptake were incorporated. Physiologically relevant differences between healthy volunteers and patients were identified in the regulation of glucose production, elimination rate of glucose, and secretion of insulin. The model was able to describe the insulin and glucose profiles well and also showed a good ability to simulate data. The features of the present model are likely to be of interest for analysis of data collected in antidiabetic drug development and for optimization of study design.
Similar articles
-
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics.J Clin Pharmacol. 2007 Oct;47(10):1244-55. doi: 10.1177/0091270007302168. J Clin Pharmacol. 2007. PMID: 17906159 Clinical Trial.
-
An integrated model for the glucose-insulin system.Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):189-94. doi: 10.1111/j.1742-7843.2009.00510.x. Epub 2009 Dec 29. Basic Clin Pharmacol Toxicol. 2010. PMID: 20050839 Review.
-
An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers.J Clin Pharmacol. 2010 Mar;50(3):246-56. doi: 10.1177/0091270009341185. Epub 2009 Nov 25. J Clin Pharmacol. 2010. PMID: 19940230
-
Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes.J Clin Pharmacol. 2011 Feb;51(2):153-64. doi: 10.1177/0091270010362536. Epub 2010 Mar 10. J Clin Pharmacol. 2011. PMID: 20220046 Clinical Trial.
-
Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.Diabetes Metab. 1996 Dec;22(6):397-406. Diabetes Metab. 1996. PMID: 8985647 Review.
Cited by
-
Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes.Interface Focus. 2016 Apr 6;6(2):20150075. doi: 10.1098/rsfs.2015.0075. Interface Focus. 2016. PMID: 27051506 Free PMC article. Review.
-
Impact of Obesity on Postprandial Triglyceride Contribution to Glucose Homeostasis, Assessed with a Semimechanistic Model.Clin Pharmacol Ther. 2022 Jul;112(1):112-124. doi: 10.1002/cpt.2604. Epub 2022 May 15. Clin Pharmacol Ther. 2022. PMID: 35388464 Free PMC article.
-
Model-Based Conditional Weighted Residuals Analysis for Structural Model Assessment.AAPS J. 2019 Feb 27;21(3):34. doi: 10.1208/s12248-019-0305-2. AAPS J. 2019. PMID: 30815754 Free PMC article.
-
Model-Based Residual Post-Processing for Residual Model Identification.AAPS J. 2018 Jul 2;20(5):81. doi: 10.1208/s12248-018-0240-7. AAPS J. 2018. PMID: 29968184
-
Study reanalysis using a mechanism-based pharmacokinetic/pharmacodynamic model of pramlintide in subjects with type 1 diabetes.AAPS J. 2013 Jan;15(1):15-29. doi: 10.1208/s12248-012-9409-7. Epub 2012 Oct 2. AAPS J. 2013. PMID: 23054970 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases